Z9A-24347-72685
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 967 / HI
- Registered
- 2021-10-12
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-10-11
Dose 3 — Pfizer-BioNTech
-
2021-10-12
Registered in v-safe
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2022-01-10
-
2022-04-11
Survey response — 6 months, dose 3MedDRA: Nausea, Throat irritation, Vomiting — Feeling: Good · Be unable to work or attend schoolFree text: Itchy throat, nausea, vomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-10-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | No |
| 2 | 2021-01-12 | Pfizer-BioNTech | No |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Itchy throat, nausea, vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release